4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-043738
President and CEO sold 204 shares at $35.53 ($7,248)
- President and CEO acquired 204 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mack David Henry President and CEO | 2021-06-28 | Option exercise | +204 | $0.53 | $108 | 12,674 | D: show line 1 in the form |
| Mack David Henry President and CEO | 2021-06-28 | Sale | −204 | $35.53 | $7,248 | 12,470 | D: show line 2 in the form |
| Open-market sales · 204 sh · avg $35.53 · $7,248 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Mack David Henry President and CEO | 2021-06-28 | Option exercise · Stock Option (right to buy) | −204 | 474,870 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…